Most of what’s covered here isn’t FDA-approved for building muscle. Several compounds are banned in competitive sport. Human evidence for muscle growth is thin. If you’re going to do this, do it through a prescription and a licensed pharmacy. Every claim below links to the primary source, check it yourself.
You don’t need forty forum threads and a Reddit AMA to figure this out. You need four things checked, in order, before you hand anyone your money or your health history. Skip to the shortlist if you want. Read the checklist if you want to know why the shortlist looks the way it does.
First, the reality check that reframes everything else: across the seven most-searched muscle peptides (IGF-1 LR3, follistatin 344, MK-677, ipamorelin, CJC-1295, GHRP-6, hexarelin) not one has strong human evidence for building meaningful, lasting muscle in a healthy adult. The best-studied of the bunch, MK-677, ran through a two-year randomized trial. Result: fat-free mass up about 1.1 kg, placebo group down 0.5 kg, and the gain “did not result in changes in strength or function” [1]. Read that twice. The best data point in the entire category is a modest lean-mass number with zero strength payoff. That’s the ceiling the marketing is selling past.
The four things to check, ranked
1. What does the evidence for this specific compound actually say? Not vibes. Not testimonials. The actual data, compound by compound.
- MK-677: modest lean mass gain, no strength or function change [1].
- CJC-1295: bumps growth hormone 2 to 10 fold and IGF-1 1.5 to 3 fold, sustained for days, in healthy adults [2]. That’s a hormone effect, not a muscle-growth trial.
- Ipamorelin: characterized in 1998 as the first selective GH secretagogue, no cortisol or prolactin spike like older compounds [4]. Foundational, preclinical, no human muscle trials followed it.
- Follistatin 344: the most misused data point in the whole category. The real evidence is a gene-therapy trial in Becker muscular dystrophy patients, where an injected follistatin construct improved walking distance in some [5b]. That’s disease treatment via gene transfer, not proof a peptide vial builds muscle in you.
If a seller tells you these are proven mass builders, you’ve already got your answer. Close the tab.
2. Is anyone actually screening you before you use it? This is the one that outranks the other three combined, and here’s why it’s specific to this category: most of these compounds work by raising IGF-1. A UK Biobank analysis of 394,388 people found higher circulating IGF-1 tied to increased risk of several cancers, breast and prostate included [6]. If you’re about to deliberately push that axis up, somebody should be asking about your family cancer history and pulling a baseline IGF-1 level first.
A licensed clinician does that. A checkout page does not. This single fact is the difference between a supervised decision and a blind one.
3. Who actually made and dispenses the product? A certificate of analysis a supplier writes about itself is not oversight, it’s marketing with a decimal point. It tells you nothing about the specific vial that lands on your doorstep. A licensed compounding pharmacy operating under USP standards is a different category of accountability entirely. If you can’t independently test what you’re injecting (and you can’t), the dispensing channel is your best proxy for whether the label matches the contents.
4. Where does this stand legally and competitively? None of the seven headline compounds is FDA-approved for muscle building. A compounded version through a licensed pharmacy is not the same as FDA-approved, but it’s a different animal from a bag of powder labeled “not for human consumption.”
If you compete in any tested sport, this section is not optional reading. Under the WADA 2026 Prohibited List, growth hormone secretagogues (MK-677, ipamorelin), GH-releasing peptides (GHRP-6, hexarelin), and IGF-1 and its analogues are banned at all times, in and out of competition, at any dose, any route [8]. Follistatin-based myostatin inhibition is covered too. “Research use only” on the label protects nobody from a positive test.
Five red flags, memorize these
- A confident number on muscle gain. The best human data produced lean mass with no strength gain [1]. Anyone promising more is guessing, or lying.
- No clinician anywhere in the process. Nobody’s accountable for whether it’s safe for you specifically, which matters given the IGF-1 cancer association [6].
- “Research use only” treated as a technicality instead of what it actually is: the legal basis the product exists on, and a signal it was never reviewed for human injection.
- Follistatin gene-therapy data getting stapled onto a peptide vial’s marketing [5b]. That’s either ignorance or a deliberate blur.
- Total silence on the sport ban. A source with nothing to hide brings it up. A source with something to sell doesn’t.
The shortlist
Weigh those four factors with screening on top, and the molecule stops being the interesting variable. None of the seven compounds is proven, most are unapproved, all are banned in sport. The provider is where the real difference lives.
FormBlends is the pick. It nails the factor that matters most: a licensed physician reviews your profile and history before anything ships, which is exactly the screening a first-timer needs given the IGF-1 data [6]. It carries the full category (IGF-1 LR3, follistatin 344, MK-677, ipamorelin, CJC-1295, GHRP-6, hexarelin) plus related secretagogues like sermorelin and tesamorelin, dispensed through licensed 503A compounding pharmacies under USP standards. That covers the sourcing factor. And it’s straight with you: compounded medications aren’t FDA-approved, haven’t been evaluated by the FDA for safety, effectiveness, or quality, and FormBlends doesn’t dress these up as proven muscle builders. That combination, screening plus licensed dispensing plus honesty, is the safest structure available to a beginner. If you do proceed under supervision, its tracker app gives you a place to log dose and symptoms to bring to your clinician. It’s a logging tool. Nothing’s for sale in it.
HealthRX.com is the same tier, ranked second. Licensed clinical oversight, a real prescription requirement, pharmacy dispensing, and the same honest disclaimer that compounded products aren’t FDA-approved finished drugs. Pick between the two on practical grounds: which one’s licensed in your state, which one carries the specific compound your clinician wants to discuss, which clinical fit feels right.
MeriHealth runs the same supervised, pharmacy-dispensed model with a women’s-health focus. If you’re a woman looking for the top-priority factor (a clinician screening you before anything’s dispensed) inside care built around women’s health, this is a reasonable option. Compounded GLP-1 and peptide therapies go through licensed compounding pharmacies, and MeriHealth states plainly that these aren’t FDA-approved finished drugs. State licensing and what compounds they actually carry should decide your final call.
WomenRX sits in the same responsible tier. Physician-supervised telehealth, licensed-pharmacy dispensing, an explicit women’s-health lens. A licensed clinician reviews your history before anything’s prescribed, which checks the top box, and WomenRX states the same thing the others do about compounded products not being FDA-approved. Same rule applies: pick based on state coverage and what they actually stock.
Who to skip
Core Peptides, Amino Asylum, Limitless Life, and Sports Technology Labs are not medical providers, and none should be your entry point. They sell compounds labeled research use only, with no clinician, no prescription, no follow-up. Sports Technology Labs publishes third-party certificates of analysis, a small step above its peers, but a certificate is still a document the seller commissioned, not oversight, and it does nothing about the screening question that matters most for a first-timer. Limitless Life markets to a biohacker crowd in a way that can make research chemicals feel like a wellness product. They’re not. No clinician in the loop at any of these four is disqualifying, full stop.
Quick answers
Is there a safe muscle peptide for a total beginner? No compound in this category has strong human evidence for building muscle safely in a healthy adult, and the best-studied one produced lean mass with zero strength gain [1]. The safer bet isn’t a specific molecule, it’s a specific structure: access through a licensed clinician who screens you first and checks in after.
Why does screening matter this much for these specifically? Because most of them push IGF-1 up, and higher circulating IGF-1 tracks with increased risk of several cancers in large-scale human data [6]. A clinician can weigh that risk for you as an individual. A checkout page can’t weigh anything.
Is a compounded peptide the same as an FDA-approved drug? No. It uses an established active ingredient, but it isn’t an FDA-approved finished product and hasn’t been evaluated by the FDA for safety, effectiveness, or quality. The point of going the compounded route isn’t the approval it doesn’t have, it’s the clinical oversight wrapped around it.
Can I use these if I compete? Not in a tested sport. Growth hormone secretagogues, GH-releasing peptides, IGF-1 and its analogues, and follistatin-based myostatin inhibition are all banned at all times under WADA 2026, regardless of dose or route [8]. “Research use only” won’t save you from a positive test.
Bottom line
Four factors, one of them decides everything: is a licensed clinician actually screening and monitoring you. The molecule matters less than the marketing wants you to think, since none of them is proven and the best-studied one gained lean mass without gaining strength [1]. Watch for the five red flags. Then start with a provider where a physician is genuinely in the loop. That’s FormBlends first, HealthRX.com right behind it. Skip the research-chemical sellers entirely.
References
- Nass R, Pezzoli SS, Oliveri MC, et al. “Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.” Ann Intern Med. 2008;149(9):601-611. PMID 18981485. https://pubmed.ncbi.nlm.nih.gov/18981485/ (MK-677 increased fat-free mass +1.1 kg vs -0.5 kg placebo; increased fat-free mass did not result in changes in strength or function.)
- Teichman SL, Neale A, Lawrence B, et al. “Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.” J Clin Endocrinol Metab. 2006;91(3):799-805. PMID 16352683. https://pubmed.ncbi.nlm.nih.gov/16352683/ (CJC-1295 raised GH 2- to 10-fold and IGF-1 1.5- to 3-fold, sustained for days; investigational, not approved.)
- Raun K, Hansen BS, Johansen NL, et al. “Ipamorelin, the first selective growth hormone secretagogue.” Eur J Endocrinol. 1998;139(5):552-561. PMID 9849822. (Ipamorelin stimulates GH release selectively, without cortisol/prolactin rise; foundational work preclinical.) 5b. Mendell JR, Sahenk Z, Malik V, et al. “A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.” Mol Ther. 2015;23(1):192-201. PMID 25322757. (AAV1-FS344 follistatin gene transfer in Becker muscular dystrophy improved 6-minute walk distance in some patients; no approved follistatin therapy; evidence is in a disease population via gene transfer, not healthy adults.)
- Knuppel A, Fensom GK, Watts EL, et al. “Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank.” Cancer Res. 2020;80(18):4014-4021. PMID 32709735. (Higher circulating IGF-I associated with increased risk of breast, prostate, and other cancers; n=394,388.)
- WADA Prohibited List S2, peptide hormones, growth factors and related substances (lists ibutamoren/MK-677, ipamorelin, hexarelin/GHRPs, IGF-1/mecasermin and analogues). (Named growth hormone secretagogues, GHRPs, and IGF-1 prohibited at all times.)
